Alcoholic Liver Disease: Pathogenesis and New Therapeutic Targets

Slides:



Advertisements
Similar presentations
Recent Advances in understanding Alcoholic Liver Disease
Advertisements

Don C. Rockey  Clinical Gastroenterology and Hepatology 
Oxidants and antioxidants in alcohol-induced liver disease
Bin Gao, Hidekazu Tsukamoto  Gastroenterology 
Louise E. Glover, Sean P. Colgan  Gastroenterology 
Lipids in Liver Disease: Looking Beyond Steatosis
Abhishek Chauhan, David H. Adams  Gastroenterology 
Pathways of liver injury in alcoholic liver disease
Volume 143, Issue 5, Pages (November 2012)
Volume 148, Issue 1, Pages (January 2015)
The inflammasome in liver disease
Obesity, inflammation, and liver cancer
T. Vescovo, G. Refolo, G. Vitagliano, G.M. Fimia, M. Piacentini 
Oxidants and antioxidants in alcohol-induced liver disease
Volume 57, Issue 1, Pages 6-8 (July 2012)
Don C. Rockey  Clinical Gastroenterology and Hepatology 
Volume 142, Issue 6, Pages (May 2012)
Microbial Influences in Inflammatory Bowel Diseases
Volume 49, Issue 5, Pages (November 2008)
Gut Microbiota: Mining for Therapeutic Potential
Fatty Acid-Induced T Cell Loss Greases Liver Carcinogenesis
Is Hepatitis C Virus Carcinogenic?
Roles for Chemokines in Liver Disease
Volume 137, Issue 6, Pages e2 (December 2009)
Ira J. Fox, Stephen C. Strom  Gastroenterology 
Mechanisms of Hepatic Fibrogenesis
Volume 137, Issue 4, Pages e5 (October 2009)
Arun J. Sanyal, Veronica Miller  Gastroenterology 
Volume 134, Issue 2, Pages (February 2008)
Macrophage heterogeneity, phenotypes, and roles in renal fibrosis
Volume 134, Issue 5, Pages (May 2008)
Mesenchymal Stromal Cells: Facilitators of Successful Transplantation?
Inflammation, Autophagy, and Obesity: Common Features in the Pathogenesis of Pancreatitis and Pancreatic Cancer  Ilya Gukovsky, Ning Li, Jelena Todoric,
Signalling pathways in alcohol-induced liver inflammation
I. Carmona, P. Cordero, J. Ampuero, A. Rojas, M. Romero-Gómez 
Gaps in Knowledge and Research Priorities for Alcoholic Hepatitis
Mechanisms of iron hepatotoxicity
Biology and Treatment of Eosinophilic Esophagitis
Abrogation of the Antifibrotic Effects of Natural Killer Cells/Interferon-γ Contributes to Alcohol Acceleration of Liver Fibrosis  Won–Il Jeong, Ogyi.
Nitin Raj, Laura D. Attardi  Current Biology 
Volume 146, Issue 5, Pages (May 2014)
Viral Hepatitis in Liver Transplantation
Figure 6 Innate lymphoid cells in liver inflammation
Pathways of liver injury in alcoholic liver disease
Obesity, Inflammation, and Insulin Resistance
Celiac Disease: From Pathogenesis to Novel Therapies
Volume 134, Issue 4, Pages (April 2008)
YAPping About Glutaminolysis in Hepatic Fibrosis
Bin Gao, Hua Wang, Fouad Lafdil, Dechun Feng  Journal of Hepatology 
Direct-Acting Antivirals Cure Innate Immunity in Chronic Hepatitis C
Percy A. Knolle, Robert Thimme  Gastroenterology 
Nicolas Goossens, Yujin Hoshida  Gastroenterology 
HCV, Iron, and Oxidative Stress: The New Choreography of Hepcidin
Volume 146, Issue 4, Pages e1 (April 2014)
Herbert Tilg, Gökhan S. Hotamisligil  Gastroenterology 
Antifibrotic therapy in chronic liver disease
A View to Natural Killer Cells in Hepatitis C
Macrophages in Tissue Repair, Regeneration, and Fibrosis
Nuclear Factor-κB in the Liver: Friend or Foe?
Claire Z. Larter, Geoffrey C. Farrell  Journal of Hepatology 
Maria Rescigno, Iliyan D. Iliev  Gastroenterology 
Volume 148, Issue 3, Pages (March 2015)
Figure 1 NAFLD pathogenesis
Lipids in Liver Disease: Looking Beyond Steatosis
Volume 142, Issue 4, Pages e6 (April 2012)
Cigarette Smoke Resets the Alarmin IL-33 in COPD
Volume 137, Issue 6, Pages e2 (December 2009)
Nathalie Ganne-Carrié, Pierre Nahon  Journal of Hepatology 
Sander Lefere, Frank Tacke  JHEP Reports 
Clara Abraham, Ruslan Medzhitov  Gastroenterology 
Presentation transcript:

Alcoholic Liver Disease: Pathogenesis and New Therapeutic Targets Bin Gao, Ramon Bataller  Gastroenterology  Volume 141, Issue 5, Pages 1572-1585 (November 2011) DOI: 10.1053/j.gastro.2011.09.002 Copyright © 2011 AGA Institute Terms and Conditions

Figure 1 Spectrum of ALD, risk factors, and comorbidity. More than 95% of heavy drinkers develop fatty liver, but only up to 35% of this population develops more severe forms of ALD, including fibrosis, alcoholic hepatitis, cirrhosis, and HCC. Many risk factors have been proposed for the severe forms of ALD. Alcohol consumption and comorbid factors act in synergy to accelerate the progression of ALD. Gastroenterology 2011 141, 1572-1585DOI: (10.1053/j.gastro.2011.09.002) Copyright © 2011 AGA Institute Terms and Conditions

Figure 2 Mechanisms of alcoholic fatty liver. (1) Alcohol consumption can directly (via acetaldehyde) or indirectly (via regulation of multiple factors) up-regulate the expression of SREBP-1c and down-regulate the expression of PPAR-α, leading to the induction of fatty acid synthesis and inhibition of fatty liver β-oxidation, which results in the development of alcoholic fatty liver. Alcohol exposure also inhibits AMPK and subsequently increases ACC activity but decreases carnitine palmitoyltransferase 1 (CPT-1) activity, leading to an increase in fatty acid synthesis and a decrease in fatty acid β-oxidation. (2) Alcohol consumption can also modify many factors, including HIF-1, C3, C1qa, PKCε, and iNOS, that subsequently contribute to the development of fatty liver. The mechanisms underlying the effects of these factors remain unclear. Gastroenterology 2011 141, 1572-1585DOI: (10.1053/j.gastro.2011.09.002) Copyright © 2011 AGA Institute Terms and Conditions

Figure 3 Mechanisms underlying inflammation in ALD. (1) Activation of innate immunity. Parenchymal infiltration of neutrophils and macrophages is a prominent feature of ALD and is likely due to ethanol-mediated activation of innate immunity and subsequent induction of proinflammatory cytokines and chemokines. Alcohol consumption up-regulates a variety of factors that activate Kupffer cells, stellate cells, and hepatocytes, resulting in the production of cytokines and chemokines. Alcohol exposure also decreases proteasome activity and elevates IL-8 expression in hepatocytes. (2) Activation of adaptive immunity. ALD is associated with infiltration of CD4+ and CD8+ T cells in the liver. Alcohol consumption induces reactive oxygen species (ROS) and causes the formation of many protein adducts that might serve as antigens in the adaptive immune response, resulting in the accumulation of T and B cells in the liver. Gastroenterology 2011 141, 1572-1585DOI: (10.1053/j.gastro.2011.09.002) Copyright © 2011 AGA Institute Terms and Conditions

Figure 4 Mechanisms of liver fibrosis in patients with ALD. (1) Alcohol consumption causes hepatocyte damage, which leads to the release of a variety of mediators and the subsequent induction of stellate cell activation. (2) Acetaldehyde directly targets stellate cells and up-regulates the expression of collagens in these cells. (3) Alcohol consumption results in elevation of LPS levels in the liver. LPS can directly enhance stellate cell activation via up-regulation of TGF-β signaling and indirectly promote stellate cell activation via activation of Kupffer cells to release profibrotic cytokines and chemokines. (4) Natural killer (NK) cells are activated during viral hepatitis or IFN-α therapy. Activated natural killer cells can kill stellate cells by releasing TRAIL and inhibit stellate cell proliferation by releasing IFN-γ; they therefore have an important role in inhibiting liver fibrosis. Alcohol consumption suppresses the antifibrotic effects of NK cells and IFN-γ, thereby promoting liver fibrosis. Gastroenterology 2011 141, 1572-1585DOI: (10.1053/j.gastro.2011.09.002) Copyright © 2011 AGA Institute Terms and Conditions

Figure 5 Algorithms for treatment of compensated ALD and decompensated ALD with superimposed AH. DF, discriminant function; MELD, Model for End-Stage Liver Disease; ABIC, age/bilirubin/international normalized ratio/creatinine scoring system; OLT, orthotopic liver transplantation. Gastroenterology 2011 141, 1572-1585DOI: (10.1053/j.gastro.2011.09.002) Copyright © 2011 AGA Institute Terms and Conditions